Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

United Therapeutic NASDAQ: UTHR-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

More stories below advertisement

Latest Press Releases

United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs
Business Wire - Fri Jan 21, 5:00AM CST
Business Wire - PRTGAM
Fri Jan 21, 5:00AM CST
United Therapeutics Corporation ( UT ) (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, announced today that the world's first recipient of an investigational genetically-modified...
United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst
Business Wire - Thu Dec 30, 2021
Business Wire - PRTGAM
Thu Dec 30, 2021
United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer, and Michael Benkowitz, President and Chief Operating Officer of United Therapeutics, will provide an overview...
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022
Business Wire - Fri Dec 3, 2021
Business Wire - PRTGAM
Fri Dec 3, 2021
United Therapeutics (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2022. This award...
3D Systems and United Therapeutics Announce Expansion of Bioprinting Program
Globe Newswire - Wed Oct 27, 2021
Globe Newswire - PRTGAM
Wed Oct 27, 2021
Amendment expands program from a singular focus on the bioprinting of human lung scaffolds to the development and demonstration of two additional human...
Volumetric to Be Acquired by 3D Systems to Advance Tissue and Organ Manufacturing
Business Wire - Wed Oct 27, 2021
Business Wire - PRTGAM
Wed Oct 27, 2021
Volumetric , a Houston-based biofabrication start-up company developing biomaterials and advanced 3D bioprinting technologies, announced today it has entered into an agreement to be acquired by 3D Systems (NYSE:DDD) in a deal structured as $45...
United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021
PR Newswire - Wed Oct 27, 2021
PR Newswire - PRTGAM
Wed Oct 27, 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2021 financial results before the market...
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021
PR Newswire - Thu Oct 21, 2021
PR Newswire - PRTGAM
Thu Oct 21, 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With New Drug Application Acceptance From the FDA
Globe NewsWire - Wed Jun 16, 2021
Globe NewsWire - PRTGAM
Wed Jun 16, 2021
DANBURY, Conn., June 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics Corporation (Nasdaq: UTHR) reached a major milestone today with the announcement that the U.S. Food and Drug Administration (FDA)...
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
Globe NewsWire - Mon Apr 19, 2021
Globe NewsWire - PRTGAM
Mon Apr 19, 2021
Following Afrezza®, Tyvaso DPI is the second compound formulated with Technosphere® technology to be reviewed by FDA
Wingstop, Guess rise; CarMax, Emergent BioSolutions fall
Associated Press - Thu Apr 1, 2021
Associated Press - AP
Thu Apr 1, 2021
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Thursday:

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies